Resveratrol (trans-3,4′,5-trihydroxystilbene) decreases lipid peroxidation level and protects antioxidant capacity in sera and erythrocytes of old female Wistar rats induced by the kidney carcinogen potassium bromate

Environmental Toxicology and Pharmacology

Volumn 24, Issue 2, 2007, Pages 79-85

  Yilmaz, Ökkeş ^a   Keser, Serhat ^a   Tuzcu, Mehmet ^a   Çetintaş, Buket ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Cholesterol; Erythrocytes; Glutathione; Homocysteine; KBrO3; Lipid peroxidation; Lipophylic vitamins; Resveratrol; Serum

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARCINOGEN; CHOLESTEROL; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; POTASSIUM BROMATE; RESVERATROL;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT;

RATTUS; RATTUS NORVEGICUS; VITACEAE;

EID: 34447622109     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2007.05.007     Document Type: Article

References (57)

1. Armutcu F., Coskun O., Gurel A., Sahin S., Kanter M., Cihan A., Numanoglu K.V., and Altinyazar C. Vitamin E protects against acetone-induced oxidative stress in rat red blood cells. Cell Biol. Toxicol. 21 1 (2005) 53-60
2. Arteel G.E., and Sies H. The biochemistry of selenium and the glutathione system. Environ. Toxicol. Pharmacol. 10 4 (2001) 153-158
3. Aziz M.H., Kumar R., and Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23 (2003) 17-28
4. Bhat K.P.L., Kosmeder J.W., and Pezzuto J.M. Biological effects of resveratrol. Antioxid. Redox Signall. 3 6 (2001) 1041-1106
5. Bowers J.L., Tyulmenkov V.V., Jernigan S.C., and Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141 10 (2000) 3657-3667
6. Bragagnolo N., and Rodriguez-Amaya D.B. Comparison of the cholesterol content of Brazilian chicken and quail eggs. J. Food. Comp. Anal. 16 2 (2003) 147-153
7. 3. Free Radic. Biol. Med. 26 (1999) 1531-1537
8. Cao Y., Wang F., Liu H.Y., Fu Z.D., and Han R. Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells. J. Asian Nat. Products Res. 7 4 (2005) 633-641
9. Chipman J.K., Davies J.E., Parsons J.L., Nair J., O'Neill G., and Fawell J.K. DNA oxidation by potassium bromate; a direct mechanism or linked to lipid peroxidation. Toxicology 998 126 (1998) 93-102
10. Clemens M.R., and Waller H.D. Lipid peroxidation in erythrocytes. Chem. Phys. Lipids 45 2-4 (1987) 251-268
11. de la Lastra C.A., and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49 (2005) 405-430
12. 1 mice and F344/N rats. Toxicol. Pathol. 26 (1998) 587-594
13. Devi S.A., Subramanyam M.V.V., Vani R., and Jeevaratnam K. Adaptations of the antioxidant system in erythrocytes of trained adult rats: impact of intermittent hypobaric-hypoxia at two altitudes. Comp. Biochem. Physiol. 140 Part C (2005) 59-67
14. Doubek J., Volny T., Lojek A., Knotkova Z., Kotrbacek V., Scheer P., and Holesovska Z. Effect of stilbene resveratrol on haematological indices of rats. Acta Vet. Brno (2005) 74
15. Foreman M.G., Ten Hoor T., Brown L.A.S., and Moss M. Effects of chronic hepatic dysfunction on pulmonary glutathione homeostasis. Alcohol. Clin. Exp. Res. 26 12 (2002) 1840-1845
16. Galati G., Sabzevari O., Wilson J.X., and O'Brien P.J. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 177 (2002) 91-104
17. Gradinski-Vrbanac B., Stojevic Z., Milinkovic-Tur S., Balenovic T., Pirsljin J., and Zdelar-Tuh M. In vitro susceptibility of duck, chicken, and pig erythrocyte lipids to peroxidation. Vet. Med. 47 10-11 (2002) 303-308
18. Gupta M., Sharma P., Garg G., Kaur K., Bedi G.K., and Vij A. Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease. Clin. Chim. Acta 352 1-2 (2005) 121-125
19. Gusman J., Malonne H., and Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22 (2001) 1111-1117
20. Ignatowicz E., and Baer-Dubowska W. Resveratrol a natural chemopreventive agent against degenerative diseases. Pol. J. Pharmacol. 53 (2001) 557-569
21. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.S.S., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
22. Katsanidis E., Addis P.B., and Novel. HPLC analysis of tocopherols, and cholesterol in tissue. Free Radic. Biol. Med. 27 11-12 (1999) 1137-1140
23. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Malone W.A., Bone C.W., et al. Progress in cancer chemoprevention: development of dietderived chemopreventive agents. J. Nutr. 130 (2000) 467S-471S
24. King R.E., Kent K.D., and Bomser J.A. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem. Biol. Interact. 151 2 (2005) 143-149
25. Kolouchova I., Melzoch K., Smidrkal J., and Filip V. The content of resveratrol in vegetables and fruit. Chem. Listy. 99 7 (2005) 492-495
26. Kowalski J., Samojedny A., Paul M., Pietsz G., and Wilczok T. Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1 beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol. Rep. 57 3 (2005) 390-394
27. Kuo H.K., Yen C.J., and Bean FJ.F. Levels of homocysteine are inversely associated with cardiovascular fitness in women, but not in men: data from the National Health and Nutrition Examination Survey 1999-2002. J. Intern. Med. 258 4 (2005) 328-335
28. Kurata M., Suzuki M., and Agar N.S. Glutathione regeneration in mammalian erythrocytes. Comp. Haematol. Int. 10 2 (2000) 59-67
29. Laden B.P., and Porter T.D. Resveratrol inhibits human squalene monooxygenase. Nutr. Res. 21 5 (2001) 747-753
30. Landrault N., Poucheret P., Ravel P., Gasc F., et al. Antioxidant capacities and phenolics levels of French wines from different varieties and vintages. J. Agric. Food Chem. 49 (2001) 3341-3348
31. 3), a renal oxidative carcinogen. Mutat. Res. 364 (1996) 227-233
32. Lopez-Velez M., Martinez-Martinez F., and Del Valle-Ribes C. The study of phenolic compounds as natural antioxidants in wine. Crit. Rev. Food Sci. Nutr. 43 (2003) 233-244
33. Lu S.C. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 13 (1999) 1169-1183
34. Mansoor M.A., Svardal A.M., and Ueland P.M. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem. 200 (1992) 218-229
35. Miura D., Miura Y., and Yagasaki K. Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci. 73 11 (2003) 1393-1400
36. Miura D., Miura Y., and Yagasaki K. Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property. Clin. Exp. Metastasis 21 5 (2004) 445-451
37. Mocan H., Aksoy A., Uydu H.A., and Mocan M.C. Oxidative damage of erythrocyte membrane in nephrotic syndrome. Pediat. Nephrol. 13 4 (1999) 326-332
38. Niki E., Komuro E., Takahashi M., Urano S., Ito E., and Terao K. Oxidative hemolysis of erythrocytes and its inhibition by free-radical scavengers. J. Biol. Chem. 263 36 (1988) 19809-19814
39. Olas B., and Wachowicz B. Resveratrol a phenolic antioxidant with effects on blood platelet functions. Platelets 16 5 (2005) 251-260
40. Olas B., Wachowicz B., Majsterek I., and Blasiak J. Resveratrol may reduce oxidative stress induced by platinum compounds in human plasma, blood platelets and lymphocytes. Anti-Cancer Drugs 16 6 (2005) 659-665
41. PaceAsciak C.R., Hahn S., Diamandis E.P., Soleas G., and Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet-agreegation and eicosanoid synthesis-implications for protection against coronary heart-disease. Clin. Chim. Acta 235 2 (1995) 207-219
42. Patra R.C., Swarup D., and Dwevedi S.K. Effect of alpha-tocopherol supplementation in chelation treatment on oxidative stress indices in erythrocytes of lead exposed calves. Indian J. Anim. Sci. 72 1 (2002) 16-19
43. Peng Y., Chu Q., Liu F., and Ye J. Determination of phenolic constituents of biological interest in red wine by capillary electrophoresis with electrochemical detection. J. Agric. Food Chem. 52 (2004) 153-156
44. Rahman I., and MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic. Biol. Med. 28 9 (2000) 1405-1420
45. Rahman I., Biswas S.K., Jimenez L.A., Torres M., and Forman H.J. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid. Redox Signal. 7 1-2 (2005) 42-59
46. Renaud S.C., and De Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
47. Sai K., Takagi A., Umemura T., Hasegawa R., and Kurokawa Y. Relation of 8-hydroxydeoxyguanosine formation in rat kidney to lipid peroxidation, glutathione level and relative organ weight after a single administration of potassium bromate. Jpn. J. Cancer Res. 82 (1991) 165-169
48. Serada T.J., Mant C.T., and Hodges R.S. Use of sodium perchlorate at low pH for peptide separatios by reversed-phase liquid chromatography. Influence of perchlorate ion on apparent hydrophilicity of positively charged amino acid side-chains. J. Chromatogr. 776 (1997) 153-165
49. Soleas G.J., Diamandis E.P., and Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem. 30 (1997) 91-113
50. Trivedi R., John S., Kale M., Rathore N., and Bhatnagar D. Lipid peroxidative damage on lead exposure and alterations in antioxidant system in rat erythrocytes: role of vitamin E. Trace Elements Electrol. 14 4 (1997) 177-180
51. Turner R.T., Evans G.L., Zhang M.Z., Maran A., and Sibonga J.D. Is resveratrol an estrogen agonist in growing rats?. Endocrinology 140 1 (1999) 50-54
52. Vitrac X., Bornet A., Vanderlinde R., Valls J., Richard T., Delaunay J.C., Merillon J.M., and Teissedre P.L. Determination of stilbenes (delta-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, epsilon-viniferin) in Brazilian wines. J. Agric. Food Chem. 53 14 (2005) 5664-5669
53. Wang Z.R., Zou J.G., Huang Y.Z., Cao K.J., Xu Y.N., and Wu J.M. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin. Med. J. 115 3 (2002) 378-380
54. Wolf D.C., Crosby L.M., George M.H., Kilburn S.R., Moore T.M., Miller R.T., and DeAngelo A.B. Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats. Toxicol. Pathol. 26 (1998) 724-729
55. Wolter F., and Stein J. Biological activities of resveratrol and its analogs. Drugs Future 27 10 (2002) 949-959
56. Yoshida T. Determination of reduced and oxidized glutathione in erythrocytes by high performance liquid chromatography with ultraviolet absorbance dedection. J. Chromatogr. B 678 (1996) 157-168
57. Zern T.L., West K.L., and Fernandez M.L. Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J. Nutr. 133 7 (2003) 2268-2272